Neuroendocrine immune responses to inflammation: The concept of the neuroendocrine immune loop

Bailliere's Clinical Rheumatology

Volumn 10, Issue 2, 1996, Pages 199-225

  Chikanza, I C ^a   Grossman, A B ^a  

^a ROYAL LONDON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ACUTE PHASE RESPONSE; BRAIN; HOMEOSTASIS; HORMONE RELEASE; HUMAN; HYPOTHALAMUS; IMMUNE RESPONSE; INFLAMMATION; INFLAMMATORY DISEASE; LIVER FUNCTION; NEUROENDOCRINE SYSTEM; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

EID: 0029969925     PISSN: 09503579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0950-3579(96)80015-X     Document Type: Article

References (151)

1. Aird E Clevenger CV, Prystowsky MB & Redei E (1993) Corticotropin-releasing factor mRNA in rat thymus and spleen. Proceedings of the National Academy of Science, USA 90: 7104-7108.
2. Akira S, Hirano T, Taga T & Kishimoto T (1990) Biology of multifunctional cytokines: IL 6 and related molecules (IL 1 and TNF). FASEB Journal 4: 2860-2867.
3. AI-Damuluji S & Grossman A (1985) Adrenergic and opiod control of ACTH secretion in man. Neuroscience Letters 22: 406.
4. Amstad PA, Krupitzu G & Gerutti PA (1992) Mechanisms of c-fos induction by active oxygen. Cancer Research 52: 3952-3960.
5. Angioni S, Petraglia F, Gallinelli Aet al (1993) Corticotropin-releasing hormone modulates cytokines release in cultured human peripheral blood mononuclear cells. Life Sciences 53: 1735-1742.
6. Arend WP (1991) Interleukin-1 receptor antagonist. A new member of the interleukin-1 family. Journal of Clinical Investigation 88: 1445-1451.
7. Baeurle PA & Baltimore T (1991) The physiology of the NFkB transcription factor. In Cohen P & Foulkes JG (eds) The Hormonal Control Regulation of Gene Transcription pp 423-446.Amsterdam: Elsevier Science.
8. Bagglioni M, Walz A & Kunkel SL (1989) Neutrophil activating peptide/IL-8, a novel cytokine that activates neutrophils. Journal of Clinical Investigations 84:1045-1049.
9. Baumann H & Ganldie J (1990) The regulation of hepatic acute phase plasma genes by hepatocyte stimulating factors and other mediators of inflammation. Molecular Biology and Medicine 7:147-159.
10. Beckman JS & Crow JP (1993) Pathological implications of NO, superoxide and peroxynitrite formation. Biochemical Society Transactions 21: 330-335.
11. Berci I (1993) Prolactin, pregnancy and autoimmune disease (Editorial) Journal of Rheumatology 20: 1095-1100.
12. Bernardini R, Kamilaris TC, Calogero AE et al (1990) Interactions between tumor necrosis factor-ct, hypothalamic corticotropin-releasing hormone, and adrenocorticotropin secretion in the rat. Endocrinology 126:2876-2881.
13. Bevan S & Raynes JG (1991) IL-1 receptor antagonist regulation of acute phase protein synthesis in human hepatoma cells. Journal oflmmunology 147: 2574-2578.
14. Blalock JE (1985) Proopiomelanoeortin-derived peptides in the immune system. Clinical Endocrinology 22: 823-827.
15. Blatteis CM (1988) Neural mechanisms in the pyrogenic and acute-phase responses to interleukin-1. International Journal of Neuroscience 38: 223-232.
16. Blatteis CM, Xin L & Quan N (1994) Neuromodulation of fever: a possible role for substance E Annals of the New York Academy of Science 741: 162-172.
17. Brain SD & Williams TJ (1988) SP regulates vasodilator activity of calcitonin gene-related peptide. Nature 335: 73-75.
18. Cart DB, Bergland R, Hamilton Aet al (1982) Endotoxin-stimulated opioid peptide secretion: two secretory pools and feedback control in vivo. Science 217: 845-848.
19. Carter DB, Deibel MR, Dunn CJ et al (1990) Purification, cloning, expression and biological activity of an interleukin-1 receptor antagonist. Nature 344: 633-638.
20. Cash JM, Crofford LJ, Galluci WT et al (1992) Pituitary-adrenal axis responsiveness to ovine corticotropin releasing hormone in patients with rheumatoid arthritis treated with low dose prednisone. Journal of Rheumatology 19: 1692-1696.
21. Catania A & Lipton JM (1993) ctMSH in the modulation of host reactions. Endocrine Reviews 14: 564-576.
22. Catania A, Manfredi GM, Airaghi Let al (1994) Cytokine antagonists in infectious and inflammatory disorders. Annals of the New York Academy of Science 741: 149-161.
23. Chikanza IC (1995) Hypothalmic-pituitary adrenal effects of non-steroidal anti-inflammatory drugs. Arthritis and Rheumatism 38: 723-724.
24. Chikanza IC & Panayi GS (1991 ) Hypothalamic-pituitary mediated modulation of immune function:prolactin is a neuroimmune peptide. British Journal of Rheumatology 30: 203-207.
25. Chikanza IC & Panayi GS (1993) The effects of hydrocortisone on in vitro lymphocyte proliferation, IL-2 and IL-4 production in corticosteroid sensitive and resistant subjects. European Journal of Clinical Investigations 23: 845-850.
26. Chikanza IC, Corrigal V, Kingsley G & Panayi GS (1992a) Enumeration of interleukin-1 alpha and beta producing cells by flow cytometry. Journal oflmmunological Methods 154: 173-178.
27. Chikanza IC, Petrou R Kingsley Get al (1992b) Defective hypothalamic response to immune and inflammatory stimuli in patLents with rheumatoid arthritis. Arthritis and Rheumatism 35: 1281-1288.
28. Chikanza IC, Petrou R Chrousos GP et al (1993a) Excessive and dysregulated secretion of prolactin in rheumatoid arthritis, lmmunopathogenetic and therapeutic implications. British Journal of Rheumalology 32: 445-448.
29. Chikanza IC, Roux-Lombard P, Dayer J-M & Panayi GS (1993b) TNF soluble receptors (TNF inhibitors) behave as acute phase proteins following major surgery in patients with rheumatoid arthritis, osteomyelitis and osteoarthritis. Clinical Experimental Immunology 92: 19-22.
30. Chikanza IC, Petrou P, Panayi GS & Chrousos GP (1995) Arginine vasopressin secretion in rheumatoid arthritis: pathophysiologieal implications. Arthritis and Rheumatism 38:5216.
31. Clevenger CV, Sillman AL & Pryshwsky MB (1990) Interleukin-2 driven nuclear translocation of protactia in cloned T-lymphocytes. Endocrinology 127:3157-3159.
32. Colotta F, Re F, Muzio Met al (1993) Intefleukin-I type receptor: A decoy target for IL-1 that is regulated by IL-4. Science 261: 472-475.
33. Conlon PJ, Grastein KH, Alperl Aet al (1987) Localization of human mononuclear cell intefleukinl, Journal of Immunology 139: 98-102
34. Costa A, Trainer T, Besser GM & Grossman A (1993) Nitric oxide modulates the release of corticotropin releasing hormone from the rat hypothalamus. Brain Research 605: 187-192.
35. Crofford LJ, Sano H, Karalis K et al (1993) Corticotropin-releasing hormone in synovial fluids and tissues of patients with rheumatoid arthritis and osteoarthritis. Journal of Immunology 151:1587-1596
36. Cutolo M, Sulli A, Barone Aet al (1995) The role of androgens in the pathophysiology of rheumatoid arthritis. Fundamental and Clinical Immunology 3:9-18.
37. Daynes RA & Araneo BA (1989) Contrasting effects of glucocorticoids on the capacity of T cetls to produce growth factors interleukin-2 and interleukin-4. European Journal of Immunology 19:2319-2325.
38. Detitala G, Grossman A & Besser GM (1983) Differential effects of opiate peptides and alkaloids on anterior pituitary hormone secretion. Neuroendocrinology 37: 275-279.
39. Diamond MI, Miner JN, Yoshinaga SK & Yamamoto KR (1990) Transcription factor interactions: selectors of positive or negative regulation from single DNA element. Science 249: 1265-1273.
40. Dinarello CA (199l) lnterleukin-1 and antagonism. Blood 77: 641-647.
41. Donnerer J, Schuligoi R & Stein C (1992) Increased content and transport of substance P and calcitonin gene-related peptide in sensory nerves innervating inflamed tissue: evidence for a regulatory function of nerve growth factor in viva. Neuroscience 49: 693-698.
42. Edmonds SE, Blake DR, Morris C1 & Winyard PG (1993) An imaginative approach to synovitis-the role of hypoxic reperfusion damage in arthritis. Journal of Rheumatology 20 (supplement 37): 26-31.
43. Ekman RE, Servenius B, Castro MG et al (1993) Biosynthesis of corticotropin-releasing hormone in human T-lymphocytes. Journal of Neuroimmunology 44: 7-13.
44. Elands 1, Resinck A & De Kloet ER (1990) Neumhypophyseal hormone receptors in the rat thymus, spleen and lymphocytes. Endocrinology 126:2703-2710.
45. Engelmann H, Novick D & WalIach D (1990) Two tumor necrosis factor binding proteins purified from human urine-evidence for immunological cross-reactivity with cell surface tumour necrosis receptors. Journal of Biological Chemistry 265: 1531-1536.
46. Faria M, Navarra R Ysagarakis Set at (1990) Inhibition of CRH-41 release by substance P, but not substance K, from the rat hypothaiamus in vitro. Brain Reseatrh 538: 76-78.
47. Fischer E, van Zee KJ, Marano MAet al (1990) Interleukin-1 receptor antagonist circulates in experimental inflammation and human disease. Blood 79: 2192-2200.
48. Fitzpatrick E Chfisteff N, Durant Set al (1992) Glucocorticoids in the non-obese (NOD) mouse: basal serum levels, effect of endocrine manipulation and immobilization stress. Life Science 50:1063-1069
49. Friedl HE Till GO, Ryan US & Ward DA (1989) Mediator-induced activation of xanthine oxidase in endothelial cells. FASEB Journal 3: 2512-2518.
50. Gaillard RC, Turnill D, Sappino P & Muller AF (1990) Tumor necrosis factor inhibits the hormonal response of the pituitary gland to hypothalamic releasing factors. Endocrinology 127: 101-106.
51. German T, Gately MF, Schoenhaunt DS et al (1993) Intefleukin-12/T cell stimulating factor, a cytokine with multiple effects on Thl but not Th2 cells. European Journal of Immunology 23:1762-1770.
52. Grossman A & Costa A (1993) The regulation of hypothalamic FRH. Impact of in vitro studies on the central control of the stress response. Functional Neurology 8: 325-334.
53. Hadzhikostova H, Visheva N, Milanov S & Nikolov N (1979) Changes of ACTH, STH, TSH and prolaetin levels in endotoxic shock in rats. Agressologie 20: 203-206.
54. Hammond GL & Smith CL (1991) An amino acid substitution in BioBreeding rat corticosteroid binding globulin results in reduced steroid binding affinity. Journal of Biology and Chemistry 266:18555-18559.
55. Hanamaijer R, Koolwijk P, Le Clercq Let al (1993) Regulation of metalloproteinase expression in human vein and microvascular endothelial cells. Biochemistry Journal 296: 803-809.
56. Harbuz MS, Leonard JP, Lightman SL et al (1993) Changes in hypothalamic corticotrophin releaseing factor and pituitary POMC mRNA during the course of experimental allergic encephalomyelitis. Journal of Neurendocrinology 45: 127-132.
57. Hat-tung H, Wolters K & Toyka K (1988) Substance P: binding properties and studies on cellular responses in guinea pig macrophages. Journal of Immunology, 136: 3856-3863.
58. Henderson B, Thompson RC, Hardingham T & Lewthwaite J (1991) Inhibition of interleukin-linduced synovitis and articular proteoglycan loss in the rabbit knee by recombinant human interleukin-1 receptor antagonist. Cytokine 3: 246-249.
59. Hu Y, Dietrich H, Herold Met al (1993) Disturbed immunoendocrine communication via the hypothalamo-pituitary-adrenal axis in autoimmune disease. International Archives of AUergy and Immunology 102: 232-241.
60. Inura H, Fukata J & Mori T (1991) Cytokines and endocrine functions: an interaction between the immune and neuroendocrine systems. Clinical Endocrinology 35:107-115.
61. Jacob CO (1989) Cytokines and anti-cytokines. Current Opinion in Immunology 2: 249-257.
62. Jansky L (1992) A discrete mode of the anti-pyretic action of AVE cc-MSH and ACTH. Physiology Research 41:57-61.
63. Jattela M, Ilvesmaki V, Voutilainen R et al (1991) Tumor necrosis factor as a potent inhibitor of adrenocorticotropin-induced cortisol production and steroidogenic P450 enzyme gene expression in cultured human fetal adrenal cells. Endocrinology 128: 623-529.
64. Jessop DS, Chowdrey HS, Larsen PJ & Lightman S (1992) Substance P: multifunctional peptide in the hypothalamo-pituitary system? Journal of Endocrinology 132: 331-337.
65. Jiang Y, Belier DI, Frendl Get al (1992) Monocyte chemoattractant protein-1 regulates adhesion molecule expresion and cytokine production in human monocytes. Journal of Immunology 148:2423-2427.
66. Johnson H, Farrar WL &Torres B (1982) Vasopressin replacement of IL-2 requirement for IFNγ production: lymphokine activity of a neuroendocrine hormone. Journal of Immunology 129:983-986.
67. Jorgensen JL, Reay PA, Ehrich EW & Davis MM (1992) Molecular components of T cell recognition. Advances Reviews of Immunology 10: 835-847.
68. June CH, Ledbetter JA, Linsley PS & Thompson LB (1990) Role of CD28 receptors in T cell activation. Immunology Today 11:211-213.
69. Karalis K, Sano H, Redwine Jet al (1991) Autocrine or paracrine inflammatory actions of corticotropin-releasing hormone in vivo. Science; 25: 421-423.
70. Kashida H & Kotake Y (1994) Corticotropin-releasing hormone enhances the superoxide anion production of rabbit peritoneal macrophages simulated with N-formyl-methionyl-leucylphenyalanine. Life Sciences 34: 539-543.
71. Kasting NW, Mazurek MF & Martin JB (1985) Endotoxin increases vasopressin release independently of known physiological stimuli. American Journal of Physiology 248: E420-E424.
72. Kasting NW & Martin JB (1982) Altered release of growth hormone and thyrotropin induced by endotoxin in the rat. American Journal of Physiology 243: E332-E337.
73. Kidess AI, Caplan RH, Reynertson RH et al (1993) Transient corticotropin deficiency in critical illness. Mayo Clinic Proceedings 68: 35-41.
74. Kohler PO, O'Malley BW, Rayford PL et al (1967) Effect of pyrogen on blood levels of pituitary trophic hormones. Observations of the usefulness of the growth hormone response in the detection of pituitary disease. Journal of Clinical Endocrinology and Metabolism 27: 219-226.
75. Kovacs EJ (1991) Fibrogenic cytokines: the role of immune mediators in the development of scar tissue. Immunology Today 12: 17-23.
76. Larsen P J, Jessop D, Patel H et al (1993) Substance P inhibits the release of anterior pituitary adrenocorticotrophin via a central mechanism involving cortieotrophin-releasing factor-containing neurons in the hypothalamic paraventricular nucleus. Journal of Neuroendocrinology 5: 99-105.
77. Larsen CG, Anderson At, Appelia E et al (1989) The neutrophil-activating protein (NAP-l) is also chemostaetic for T lymphocytes. Science 243: 1464-1466.
78. Leijon K, Hammarstrom B & Holmberg D (1994) Non-obese diabetic (NOD) mice display enhanced immune responses and prolonged survival of lymphoid cells. International Immunology 6:339-345.
79. Lipton JM (1990) modulation of the host responses by the neuropeptide αMSH. Yale Journal of Biology and Medicine 63: 173-182.
80. Lipton JM & Catania A (1992) αMSH peptides modulate fever and inflammation. In Bartfai T & Ottoson D (eds) Neuroimmunology of Fever, pp 123-126. New York: Pergamon Press.
81. Lotz M, Carson DA & Vanghn JH (1987) Substance P activation of rheumatoid synoviocytes: neural pathway in pathogenesis of arthritis. Science 235: 893-895.
82. Lotz M, Vanghan J & Carson D (t988) Effect of neuropeptides on production of inflammatory cytokines by human monocytes. Science 241: 1218-1221.
83. Mackay CR & lmhof BA (1993) Cell adhesion in the immune system. Immunology Today 14: 99-102.
84. Mackiewicz A, Schooltink H, Heinrich PC & Rose-John S (1992) Complex of soluble human 1L-6-receptor/IL-6 up-regulates expression of acute phase proteins. Journal of Immunology 146:2021-2029.
85. Mackiewicz A, Kushner I & Baumann H (eds) (1993) Acute Phase Proteins, Molecular Biology, Biochemistry and Clinical Applications. Oxford: Oxford CRC Press.
86. Mapp PI & Blake DR (1995) Neuropeptides and the synovium. In Henderson B, Edwards JCW & Pettipher ER (eds) Mechanisms and Models in Rheumatoid Arthritis, pp. 317-333. LondonAcademic Press.
87. Marshall KW, Chiu B & Inman RD (1990) Substance P and arthritis: analysis of plasma and synovial fluid levels. Arthritis and Rheumatism 33: 87-90.
88. Mason D (199l) Genetic variation in the stress response: susceptibility to experimental allergic encephalomyelitis and implications for human inflammatory disease. Immunology Today 12:57-60.
89. Mason DW, Macphee IA & Antoni FA (1990) The rote of neuroendocriue system in determining genetic susceptibility to experimental allergic encephalomyelitis in the rat. Immunology 70: 1-5.
90. Mason MJ & van Epps D (1989) Modulation of IL-I, TNF and C5α-mediated murine neutrophil migration by αMSH. Journal of Immunology 142: 1646-1651.
91. Mastorakos G, Chrous0s GP & Weber JS (1993) Recombinant interleukin-6 activates the hypothalamie-pituitary-adrenal axis in humans. Journal of Clinical Endocrinology and Metabolism 77: 1690-1694.
92. Mastorakos G, Weber JS, Magiakou MA et al (1994) Hypothalamic-pituitary- adrenal axis activation and stimulation of systemic vasopressin secretion by recombinant interleukin 6 in humans: potential implications for the syndrome of inappropriate vasopressin secretion. Journal of Clinical Endocrinology and Metabolism 79: 934-939.
93. Mathew RC, Cook GA, Blum AM et al (1992) Vasoactive intestinal peptide stimulates the release of IL-5 in murine Schistosoma mansoni infection. Journal of Immunology 148: 3572-3577.
94. McInnes IB, Al-Mughales, Huang FP et al (1995) Interleukin-I 5 in T cell migration and activation in rheumatoid arthritis. Arthritis and Rheumatism 38: S235.
95. Merenich JA (1994) Hypothalamic and pituitary function in AIDS. Bailliére's Clinical Endocrinology and Metabolism 8(4): 757-767.
96. Michie HR, Manogue KR, Spriggs DR et al (1988) Detection of circulating tumor necrosis factor after endotoxin administration. New England Journal of Medicine 318:1481-1486.
97. Moncada S & Higgs EA (199 l) NO: physiology, pathophysiology and pharmacology. Pharmacology (Reviews) 43: 109-141.
98. Morita Y, Yamamura M, Harada Set al (1995) Anti-inflammatory properties of intefleukin-13 in rheumatoid synovial inflammation. Arthritis and Rheumatism 38: 353.
99. Mosmann TR, Cherwinsky H, Bond MW et al (1986) Two types of murine helper T cell clone. Definition according to profiles of lymphokine activities and secreted proteins. Journal of Immunology 136: 2348-2357.
100. Mugridge KG, Peretti M, Gheara P & Parente L (1991) αMSH reduces IL-1β effects on rat stomach preparations possibly through interference with IL-1 type l receptor. European Journal of Pharmacology 197:15l-155.
101. Murphy WJ, Durum SK & Longo DL (1993) Differential effects of growth hormone and prolactin on murine T cell development and function. Journal of Experimental Medicine 178: 231-236.
102. Navarra P, Tsagarakis S, Faria MS et al (1991) Interleukins-1 and-6 stimulate the release of corticotropin releasing hormone-41 from rat hypothalamus in vitro via the eicosanoid cyclo-oxygenase pathway. Endocrinology 128: 37-44.
103. Neeck G, Federlin K, Grail Vet al (1990) Adrenal secretion of cortisol in patients with rheumatoid arthritis. Journal of Rheumatology 17: 24-29.
104. Ohlsson K, Bjork P, Bergenfeldt M et al (1990) Interleukin-1 receptor antagonist reduces mortality from endotoxin shock. Nature 348: 550-552.
105. Parker LN, Levin ER & Lifrak ET. (1985). Evidence for adrenocortical adaptation to severe illness. Journal of Clinical Endocrinology and Metabolism 60: 947-952.
106. Patchev VK, Mastorakos G, Brady LS et al (1993) Increased arginine vasopressin secretion may participate in the enhanced susceptibility of Lewis rats to inflammatory disease. Neuroendocrinology 58: 106-110.
107. Patchev VK, Kalogeras L J, Zelazowski Pet al (1992). Increased plasma concentrations, hypothalamic content, and in vitro release of arginine-vasopressin in inflammatory disease-prone, hypothalamic CRH-deficient Lewis rats. Endocrinology 131: 1453-1457.
108. Perlstein RS, Whitnall MH, Abrams JS et al (1993) Synergistic roles of interleukin-6, interleukin-1, and tumor necrosis factor in adreno-corticotropin response to bacterial lipopolysaccharide in vivo. Endocrinology 132: 946-952.
109. Pinchot GB, Close VP & Long CNH (1949) Adrenal changes produced in rats by infection with B. tularense and B. coli. Endocrinology 45: 135-142.
110. Porat R, Poutsiaka DD, Miller LC et al (1993) Interleukin-1 receptor blockade reduces endotoxin and Borrelia burdoferi stimulated IL-8 synthesis in human mononuclear cells. FASEB Journal 51:1637-1645.
111. Rachmilewitz D, Stamler J, Karmeli F et al (1993) Peroxynitrate induced rat colitis-a new model of colonic inflammation. Gastroenterology 105: 1681-1688.
112. Reichlin S & Glaser RJ (1958) Thyroid function in experimental streptococcal pneumonia in the rat. Journal of Experimental Medicine 107: 219-235.
113. Reincke M, Hepper C, Petzke F et al (1994) Impairment of adrenocortical function with increase in plasma TNFα and IL-6 concentrations in African trypanosomiasis. Neuroimmunomodulation 1:14-22.
114. Risdon G, Cope J & Bennet M (1990) Mechanisms of chemoprevention by dietary DHEA: inhibition of lymphopoiesis. American Journal of Pathology 136: 759-769.
115. Rivier C & Vale WW (1989) In the rat, interleukin-1α acts at the level of the brain and the gonads to interfere with gonadotropin and sex steroid secretion. Endocrinology, 124: 2105-2109.
116. Roach TIA, Barton CH, Chattergee D et al (1995) Opposing effects of interferon-γ on iNOS and interleukin-10 expression in LPS and mycobacterial lipoarabinomannan-stimulated macrophages. Immunology 58:106-113.
117. Romagnani S (1991) Human Th2 and Th z subsets: doubt no more. Immunology Today 12: 256-265.
118. Rook GAW, Hernandez-Pando R & Lightman SL (1994) Hormones, peripherally activated prohormones and regulation of the Thl/Th2/balance. Immunology Today 15: 301-303.
119. Rothwell PM, Udwadia ZF & Lawler PG (1991) Cortisol responses to corticotropin and survival in septic shock. Lancet 337: 582-583.
120. Sabharwal P, Glaser R, Lafuse Wet al (1992) Prolactin synthesized and secreted by human peripheral blood mononuclear cells: an autocrine growth factor for lymphoproliferation. Proceedings of the National Academy of Science, USA 89: 7713-7716.
121. Salgame P, Abrams JS, Clayberger C et al (1991) Differing lymphokine profile of functional subsets of human CD4 and CD8 T cell clones. Science 254: 279-289.
122. Sapolsky R, Rivier C, Yamamoto Get al (1987) Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor. Science 238: 522-524.
123. S copa CD, Mastorakos G, Friedman TC et al (1994) Presence of immunoreactive corticotropin releasing hormone in thyroid lesions. American Journal of Pathology 145: 1159-1167.
124. Seckinger P, Vey E, Turcatti Get al (1990) TNF inhibitor: purification, NH2 terminal amino acid sequence and evidence for anti-inflammatory and immunomodulatory activities. European Journal of Immunology 20:1167-1174.
125. Sehgal PB, Grienninger G & Tosato G (eds) (1989) Regulation of acute phase response and immune responses: Interleukin 6. Annals of the New York Academy of Science 245: 557-564.
126. Singh VK (1989) Stimulatory effects of corticotropin-releasing neurohormone on human lymphocyte proliferation and interleukin-2 receptor expression. Journal of Neuroimmunology 23:257-262.
127. Smith RJ, Chin JE, Sam LM & Justen JM (1991). Biologic effects of an interleukin-1 receptor antagonist protein on interleukin-l-stimulated cartilage erosion and chondrocyte responsiveness. Arthritis and Rheumatism 34: 78-83.
128. Springer TA (1990) Adhesion receptors of the immune system. Nature 346: 425-428.
129. Stanisz AM, Befus & Bienenstock J (1986) Differential effects of vasoactive intestinal peptide, substance P, and soreatostatin on iremunoglobulin synthesis and proliferations by lymphocytes from Peyer's patches, mesenteric lymph nodes, and spleen. Journal of Immunology 136:152-156.
130. Stephanou A, Jessop DS, Knight RA & Lightrean SL (1990) Corticotrophin-releasing factor-like immunoreactivity and mRNA in human leukocytes. Brain Behavioural Immunology 4: 67-73.
131. Sternberg EM, Hill JM, Chrousos GP et al (1989) Inflammatory mediator-induced hypothalamicpituitary-adrenal axis activation is defective in streptococcal cell wall arthritis susceptible Lewis rats. Proceedings of the National Academy of Science, USA 86: 2374-2378.
132. Sundar SK, Cierpial MA, Kamaraju Set al (1991) Human imreunodefieiency virus gpl20 infused into rat brain induces IL-1 to elevate pituitary adrenal activity and decreases peripheral cellular immune responses. Proceedings of the National Academy of Science, USA 88: 11246-11250.
133. Suzuki H, Yasukawa K, Saito T et al (1993) Serum soluble IL-6 receptor in MRL/lpr mice is elevated with age and mediates the IL-6 signal. European Journal of Immunology 23: 1078-1084.
134. Taylor AW, Streilein JW & Cousin SW (1993) Identification of αMSH as a potential immunosuppressive factor in aqueous humour. Current Eye Research 11:1199-1206.
135. Tsagarakis S & Grossman A (1994) Cortiotrophin releasing hormone: Interactions with the immune system. Neuroimmunology 1: 329-334.
136. Tsagarakis S, Gilles G, Rees LH et al (1989) Interleukin-1 directly stimulates the release of corticotrophin releasing factor from rat hypothalamus. Neuroendocrinology 49: 98-101.
137. Udelsman R & Chrousos GP (1988) Hormonal responses to surgical stress. In Chrousos GP, Lorianx DL & Lipsett MB (eds) Advances in Experimental Medicine and Biology, pp 265-272. New York: Plenum Press.
138. Vamvakopoulos NC & Chrousos GP (1993) Evidence of direct estrogenic regulation of human corticotropin-releasing hormone gene expression. Potential implications for the sexual dimorphism of the stress response and immune/inflammatory reaction. Journal of Clinical lnvestigatons 92: 1896-1902.
139. Vankelecom H, Carmeliet P, Herereans H et al (1990) Interferon-γ inhibits stimulated adrenocorticotropin, prolactin, and growth hormone secretion in normal rat anterior pituitary cell cultures. Endocrinology 126:2919-2926.
140. Vinetti MP, Clark IM & Brinckerhoff CE (1994) Using inhibitors of reetalloproteinases to treat arthritis. Arthritis and Rheumatis 37: 1115-1126.
141. Vita R, Bresinschek RI, Lipsky PE & Oppenheimer-Marks N (1995) Interleukin-15 increases the transendothelial migration of human T cells. Arthritis and Rheumatism 38: 235.
142. Wahl SM, Hunt DA, Wony HL et al (1988) Transforming growth factor β is a potent immunosuppressive agent that inhibits IL-1 dependent lymphocyte proliferation. Journal of Immunology 140: 3026-3030.
143. Wick G, Hu Y, Gruber Jet al (1993) The role of modulatory factors in the multifaceted pathogenesis of autoimmune thyroiditis. International Reviews of Immunology 9: 77-89.
144. Wilder RL (1993) Corticotropin releasing hormone and the bypothalamic-pituitary-adrenal axis in the regulation of inflammatory arthritis. Agents Actions 41: 3-9.
145. Woods R J, Grossman A, Saphier P et al (1994) Association of human corticotropin-releasing hormone to its binding protein in blood may trigger clearance of the complex. Journal of Clinical Endocrinology and Metabolism 78: 73-76.
146. Wooley PH, Whalem JD, Chapman DL et al (1990) The effect of an interleukin-1 receptor antagonist protein on type 2 collagen and antigen-induced arthritis in mice. Arthritis and Rheumatism 33:20.
147. Wu CY, Fargeas C, Nakajima T & Delepesse G (1991) Glucocorticosteroids suppress the production of IL-4 and I1-2 by human lymphocytes. European Journal of Immunology 21: 2645-2647.
148. Yang-Yen HF, Chambard JC, Sun YL et al (1990) Transcriptional interference between c-jun and the glucocorticoid receptor: mutual inhibiton of DNA binding due to direct protein-protein interaction. Cell 62: 1205-1215.
149. Yasin S, Costa A, Trainer P et al (1993) Nilric oxide modulates the release of vasopressin from rat hypothalamic explants. Endocrinology 133:1466-1469
150. Yasin SA, Costa A, Besser GM et al (1994) Interleukin-1 and intefleukin-6 stimulate neurohypophyseal hormone release in vitro. Journal of Neuroendocrinology 6: 179-184.
151. Yssel H, Malefye RDW, Roncaroto MG et al (1992) IL-10 is produced by subsets of human CD4+ T cell clones and peripheral blood cells. Journal of Immunology 149: 2378-2384.